Answer:
Jan-10
Dr Cash $ 481,020
Cr Common stock $ 80,170
Cr Additional paid in capital in excess of stated value - Common stock $ 400,850
Mar-01
Dr Cash $ 605,920
Cr Preferred stock $ 541,000
Cr Additional paid in capital in excess of par value - Preferred stock $ 64,920
Apr-01
Dr Land $ 80,170
Cr Common stock $ 24,730
Cr Additional paid in capital in excess of stated value - Common stock $55,440
May-01
Dr Cash $ 721,530
Cr Common stock $ 80,170
Cr Additional paid in capital in excess of stated value - Common stock $ 641,360
Aug-01
Dr Incorporation charges / Legal charges $ 50,100
Cr Common stock $ 9,100
Cr Additional paid in capital in excess of stated value - Common stock $ 41,000
Sep-01
Dr Cash $ 100,100
Cr Common stock $ 9,100
Cr Additional paid in capital in excess of stated value - Common stock $ 91,000
Nov-01
Dr Cash $ 107, 060
Cr Preferred stock $ 101,000
Cr Additional paid in capital in excess of par value - Preferred stock $ 6,060
Step-by-step explanation:
Preparation of Journal entries
Jan-10
Dr Cash (80,170 * $6) $ 481,020
Cr Common stock (80,170*$1) $ 80,170
Cr Additional paid in capital in excess of stated value - Common stock $ 400,850
(481,020-80,170)
Mar-01
Dr Cash (5,410*$112) $ 605,920
Cr Preferred stock (5,410*$100) $ 541,000
Cr Additional paid in capital in excess of par value - Preferred stock $ 64,920
(605,920-541,000)
Apr-01
Dr Land $ 80,170
Cr Common stock (24,730*$1) $ 24,730
Cr Additional paid in capital in excess of stated value - Common stock $55,440
(80,170-24,730)
May-01
Dr Cash (80,170 * $9) $ 721,530
Cr Common stock (80,170*$1) $ 80,170
Cr Additional paid in capital in excess of stated value - Common stock $ 641,360
(721,530-80,170)
Aug-01
Dr Incorporation charges / Legal charges $ 50,100
Cr Common stock (9,100*$1) $ 9,100
Cr Additional paid in capital in excess of stated value - Common stock $ 41,000
(50,100-9,100)
Sep-01
Dr Cash (9,100 * $11) $ 100,100
Cr Common stock (9,100*$1) $ 9,100
Cr Additional paid in capital in excess of stated value - Common stock $ 91,000
(100,100-9,100)
Nov-01
Dr Cash (1,010*$106) $ 107, 060
Cr Preferred stock (1,010*$100) $ 101,000
Cr Additional paid in capital in excess of par value - Preferred stock $ 6,060
(107,060-101,000)